Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

CareMin650

Financiado

Cerrado

An unrivalled medical device for severe cancer treatment complications exact e...

An unrivalled medical device for severe cancer treatment complications exact easy red LED photobiomodulation for mucositis and dermatitis Today the healthcare system is under great pressure due to the increasing incidence of cancer, which is also affected by ageing of the population. However, all efforts in the medical industry have concentrated on early diagnosis a... ver más

30/04/2022

NEOMEDLIGHT

3M€

Presupuesto del proyecto: 3M€

Líder del proyecto

NEOMEDLIGHT No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 6 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2022-04-30

EIC-SMEInst-2018-2020: SME instrument

I+D

Cerrada hace 7 años

0% 70% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

6 Participantes

NEOMEDLIGHT

2.39M€ | Lider

ACCIONA CONSTRUCCION

603.18K€ | Participante

FAPERIN

233.62K€ | Participante

INPLASVA

267.79K€ | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

LEDMED New Lanthanide Basd OLEDs for Medical Treatment 45K€ Cerrado

ONCORED An unrivalled medical device based on red light photo biomo... 71K€ Cerrado

GlioLighT Next Generation Glioma Treatments using Direct Light Therapy 2M€ Cerrado

PTQ2023-013113 Investigación en oncológica radioterápica: Producto tópico p... 97K€ Cerrado

IJC2020-043482-I High precision treatment against cancer stem cells using lig... 31K€ Cerrado

MEDILIGHT Miniaturized smart system for light stimulation and monitori... 3M€ Cerrado

Duración del proyecto: 36 meses Fecha Inicio: 2019-04-08
Fecha Fin: 2022-04-30

Líder del proyecto

NEOMEDLIGHT No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 3M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Today the healthcare system is under great pressure due to the increasing incidence of cancer, which is also affected by ageing of the population. However, all efforts in the medical industry have concentrated on early diagnosis and treatment of cancer, so that this is becoming a chronic disease. The surfacing challenge from now on will be improving the quality of life of cancer patients. Mucositis and radiodermatitis are the most common and most debilitating side effects suffered by cancer patients but, so far, there is no approved preventive or curative treatment. In the last years, photobiomodulation has gained traction but the technology is still expensive, complex and inaccurate. CareMin650 is an innovative LED-based phototherapy device that will make photobiomodulation for the treatment of these conditions accurate, easy and inexpensive, thanks to its flexible fabric made of woven optic fibre. Neomedlight is proprietary of this core technology and knows a previous market success across Europe applying it to the niche market of jaundice treatment with Bilicocoon®. We now have validated the reliability of CareMin650 to deliver a fast, comfortable and painless treatment for patients; these are the added values to our central value proposition: a system for preventive and curative delivery of an accurate dose of red light. Moreover, this is a cost-effective solution to increase the quality of life and the survival of cancer patients: In the EU alone, CareMin650 will contribute to reduce the 200,000 cancer deaths and the €27.9 billion economic burden associated to mucositis and radiodermatitis. We have a huge untapped market ahead and now want to finalise CareMin650 development and achieve market preparedness. The SME Phase 2 project will allow NeoMedLight to put on the market a medical device that will boost the growth of the company, with an expected €20.8 million cumulative profit, a ROI of 5.08 and from 8 to 20 new job positions by 2025.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores